The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinicopathological features of microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC) in Japanese patients.
 
Akihito Kawazoe
No Relationships to Disclose
 
Kohei Shitara
Honoraria - Sanofi
Consulting or Advisory Role - Bayer (Inst); Chugai Pharma (Inst); Lilly (Inst); Takeda (Inst)
Research Funding - Bayer (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); Lilly (Inst); MSD (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Yakult Pharmaceutical (Inst)
 
Masaaki Noguchi
No Relationships to Disclose
 
Shota Fukuoka
No Relationships to Disclose
 
Yasutoshi Kuboki
No Relationships to Disclose
 
Hideaki Bando
Research Funding - AstraZeneca
 
Wataru Okamoto
No Relationships to Disclose
 
Takashi Kojima
Research Funding - Merck Serono (Inst); Ono Pharmaceutical (Inst); Ono Pharmaceutical (Inst)
 
Toshihiko Doi
Honoraria - Chugai Pharma; Novartis
Consulting or Advisory Role - Amgen; Lilly Japan; Merck Serono; Otsuka
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Janssen (Inst); Lilly Japan (Inst); Merck Serono (Inst); MSD (Inst); NanoCarrier (Inst); Novartis (Inst); Pfizer (Inst); Quintiles (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Zenyaku Kogyo (Inst)
 
Atsushi Ohtsu
Employment - Celgene (I)
Honoraria - Bayer Yakuhin
 
Takayuki Yoshino
Research Funding - Sumitomo Dainippon (Inst)